GENE ONLINE|News &
Opinion
Blog

AstraZeneca
M&A Alexion Pharmaceuticals
Alexion Snaps Up LogicBio Seeking Expansion into Genomic Medicines
2022-10-03
Trials & Approvals AstraZeneca
AstraZeneca’s Rare Disease Treatment Wins Third Approval in European Union
2022-09-23
Trials & Approvals Hypercholesterolemia
AstraZeneca Blocks Ionis’ Hypercholesterolemia Treatment from Moving into a Phase 3 Study
2022-09-23
Trials & Approvals RSV vaccines
AstraZeneca, Sanofi’s RSV Antibody Recommended For Approval In EU
2022-09-19
Trials & Approvals AstraZenca
AstraZeneca’s Imfinzi Combination Becomes First Approved Immunotherapy Regimen For Biliary Tract Cancer
2022-09-06
COVID-19 AstraZenca
AstraZeneca’s Role in COVID-19 Slows Down as World Looks to mRNA Vaccines
2022-08-31
COVID-19 AstraZeneca
Despite Global Acceptance, The UK Refuses to Buy AstraZeneca’s Evusheld, Citing ‘Insufficient Data’
2022-08-16
Trials & Approvals AstraZenca
AstraZeneca Calls Off Monalizumab Study With Innate After Phase 3 Disappoints
2022-08-02
China Antibody Combination
Brii Biosciences Begins Marketing COVID-19 Antibody Cocktail Therapy in China
2022-07-07
Special ASCO
ASCO 2022: AstraZeneca, Pfizer, Novartis Share Key Data on Breast Cancer Therapeutics
2022-06-07
Trials & Approvals Breast Cancer
FDA Grants AstraZeneca and Daiichi Sankyo’s Breast Cancer Drug Its Fifth Breakthrough Label
2022-04-28
Deals AstraZeneca
AstraZeneca Taps China’s AmoyDx for Companion Diagnostics
2022-04-19
Trials & Approvals Cancer
Merck Breaks Off Keytruda Combo Trial with AstraZeneca, Begins Another with Imugene
2022-03-16
Feature Digital Healthcare
UK and Taiwan to Cooperate for Breakthrough in Digital Health Innovations
2022-02-25
Trials & Approvals EU
EMA Accepts Application for AstraZeneca’s Anti-RSV Antibody Nirsevimab.
2022-02-21
1 2 3
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top